Eye Catching Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Informatica (NASDAQ:INFA), Canadian Pacific Railway Limited (NYSE:CP), EnLink Midstream, LLC (NYSE:ENLC), Trex (NYSE:TREX)

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. Currently there are 5 analysts that rate ARIAD Pharmaceuticals a buy, no analysts rate it a sell, and 6 rate it a hold. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)’s stock on 31 July traded at beginning with a price of $6.03 and when day-trade ended the stock … Continue reading Eye Catching Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Informatica (NASDAQ:INFA), Canadian Pacific Railway Limited (NYSE:CP), EnLink Midstream, LLC (NYSE:ENLC), Trex (NYSE:TREX)

John Meady08/0108/01

Healthcare ACtive Stocks: MannKind (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Bristol-Myers Squibb Co (NYSE:BMY)

MannKind Corporation (NASDAQ: MNKD) is a small company based in Valencia, California, poised to launch its FDA approved drug, Afrezza, as treatment indications for both Type 1 and Type 2 diabetes. Despite near unanimous backing from experts at the Advisory Committee (ADCOM) and the medical community, Mr. Market is still pessimistic on the company. MannKind Corporation (NASDAQ:MNKD) stock performance was -2.50% in last session and finished the … Continue reading Healthcare ACtive Stocks: MannKind (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Bristol-Myers Squibb Co (NYSE:BMY)

Jason Knox07/2807/28

Trending Stocks – Priceline (NASDAQ:PCLN) , Ariad Pharmaceuticals (NASDAQ:ARIA) , Hi-Crush Partners (NYSE:HCLP) , Rackspace (NYSE:RAX) , SMFG)

Priceline Group Inc (NASDAQ:PCLN) Director Jeffery H. Boyd sold 3,000 shares of Priceline Group stock on the open market in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $1,228.00, for a total transaction of $3,684,000.00. Following the sale, the director now directly owns 194,125 shares of the company’s stock, valued at approximately $238,385,500. Priceline Group Inc (NASDAQ:PCLN) stock … Continue reading Trending Stocks – Priceline (NASDAQ:PCLN) , Ariad Pharmaceuticals (NASDAQ:ARIA) , Hi-Crush Partners (NYSE:HCLP) , Rackspace (NYSE:RAX) , SMFG)

John Bellich07/2107/21

Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

Earlier this month, Vivus Inc. (NASDAQ:VVUS) said it filed a patent-infringement lawsuit against Actavis PLC ( ACT ) alleging that the drug maker’s planned generic version of weight-loss drug Qsymia infringes its patents. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 3.97% in last session and finished the day at $5.50. Traded volume was 4.47million shares in the last session and the average volume of the stock remained 3.04million … Continue reading Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

John Meady06/2306/23

Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

Geron Corporation (NASDAQ:GERN) on June 12 announced that the U.S. Food and Drug Administration (FDA) has removed the partial clinical hold on the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST). The partial clinical hold was placed in March 2014 due to a safety signal of hepatotoxicity that was identified in clinical trials of imetelstat. Geron Corporation (NASDAQ:GERN) stock performance was 4.01% in last … Continue reading Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

John Bellich06/1806/18

Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Drugmaker Vivus Inc. (NASDAQ:VVUS) said Thursday it has filed a lawsuit against Actavis PLC and its affiliates in a New Jersey federal court over its bid with the U.S. Food and Drug Administration to sell a generic version of company’ prescription weight-loss drug Qsymia. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -0.19% in last session and finished the day at $5.17. Traded volume was 1.03million shares … Continue reading Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Mark DeFrance06/1806/18